Cargando…
The dogma of aspirin: a critical review of evidence on the best monotherapy after dual antiplatelet therapy
Dual antiplatelet therapy based on the combination of an adenosine diphosphate (ADP)-receptor antagonist plus aspirin has demonstrated to be more effective in reducing the rate of major ischemic vascular events compared to aspirin monotherapy in some clinical settings. The current controversy on the...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561422/ https://www.ncbi.nlm.nih.gov/pubmed/26347594 http://dx.doi.org/10.1186/s12959-015-0059-8 |